Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice
- Sponsor
- Regionshospitalet Viborg, Skive
- Study ID
- NCT02322008
- Status
- Completed
Conditions
- Crohn's Disease
- Inflammatory Bowel Disease
- Ulcerative Colitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- infliximab and adalimumab — BIOLOGICALIn this retrospective, observational study, no interventions were undertaken by the researchers.
Study Details
Can genetic markers be used to predict anti-TNF response? A cohort was established to identify SNPs associated with anti-TNF therapy in patients with inflammatory bowel disease.
Key Dates
- Start date
- Sep 30, 2009
- Status verified
- Dec 2014
- Primary completion
- Mar 31, 2011
- Completion
- Mar 31, 2011
Study Design
- Enrollment
- 1,035 participants (actual)
Primary Outcome Measure
3-step scale [ Time Frame: 22 weeks ]
Related Studies
- Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Autologous Stem Cell Transplantation for Crohn's DiseasePHASE1/PHASE2 · Recruiting · Paul Szabolcs · Pittsburgh, Pennsylvania
- A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel DiseaseRecruiting · University of California, San Francisco · San Francisco, California
- Gene Expression in Inflammatory Bowel DiseaseEnrolling By Invitation · Johns Hopkins University · Baltimore, Maryland